Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩37.73T | 181.4x | -2.68 | ₩183,300 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.6% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.88T | -1,131.6x | -12.26 | ₩107,600 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.03T | -80.9x | 12 | ₩95,700 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.56T | ₩21,300 | 8.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.45T | -32.9x | 4.69 | ₩81,100 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.38T | -27x | 0.05 | ₩29,600 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.08T | 36.2x | 0.03 | ₩23,000 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioneer | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩492.2B | -19.3x | 0.03 | ₩19,000 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomictree | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩439.35B | -22.1x | -7.81 | ₩18,390 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩434.4B | -16x | -1.63 | ₩25,450 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SillaJen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩396.99B | -14.1x | 1.92 | ₩2,900 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medipost | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩362.81B | -29.5x | -0.78 | ₩10,200 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ToolGen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩349.09B | -6.8x | 0.04 | ₩40,700 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AprilBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩348.92B | ₩15,650 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Vaxcell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩279.14B | -27.6x | -32.99 | ₩12,030 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genexine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩260.6B | -4.4x | -0.09 | ₩5,650 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Corestem | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩256.52B | -6.2x | 0.12 | ₩12,330 | 13.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellivery | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩248.38B | -0.44 | ₩6,680 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
PharmAbcine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩233.76B | -0.42 | ₩2,915 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Amicogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩186.65B | -5.1x | 0.94 | ₩3,450 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩179.09B | -3.7x | 0.09 | ₩7,150 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AptaBio Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩177.15B | -7.2x | 0.17 | ₩6,450 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
iNtRON Biotechnology | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩176.92B | -37.2x | -0.76 | ₩5,430 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nibec | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩175.92B | ₩16,680 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
NKMAX | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩172.74B | 31.1x | 0.2 | ₩2,020 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB BioStep | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩169.65B | -33.9x | 0.05 | ₩2,005 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GeneOne Life Science | Seoul | Healthcare | Biotechnology & Medical Research | ₩168.44B | -2.3x | 0.07 | ₩2,110 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Macrogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩165.25B | -8x | -3.22 | ₩16,620 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medpacto | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩160.68B | -6.5x | -0.18 | ₩4,655 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bridge Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩153.5B | -3.5x | -0.22 | ₩2,965 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |